UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): May 27, 2015
AMERICAN BIOGENETIC SCIENCES, INC.
(Exact Name of
Registrant as Specified in its Charter)
| Delaware | 11-2655906 |
| (State of Incorporation) | (I.R.S. Employer Identification No.) |
| 79 East Putnam Ave, Greenwich, CT | 06830 |
| (Address of Principal Executive Offices) | (ZIP Code) |
Registrant's telephone number, including area code: (203) 297-6100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 27, 2015, the board of directors of American Biogenetic
Sciences, Inc. (the "Registrant") appointed Mr. Troy Grogan to the
Registrant's board of directors and, at the same time, appointed Mr. Grogan
to serve as the Registrant's chief financial officer. Mr. Grogan has been a
principal shareholder of the Registrant since August 2010. Prior to Mr.
Grogan's appointment, Mr. Richard Rubin had been the Registrant's sole
executive officer and director. Mr. Rubin will continue to serve as the
Registrant's chief executive officer and as chairman of the board of
directors. Troy Grogan, age 38, was the founder, president and chief executive
officer of MedScience Research Group, Inc., a private company incorporated
in May 2013. MedScience is an early stage company engaged in the
development, acquisition and distribution of proprietary diagnostic medical
equipment directed to the primary care market for a range of diagnostic
testing of the most common chronic health conditions, principally in the
U.S. Prior to MedScience, Mr. Grogan was an entrepreneur with business
experience in preventative health care in Australia and North America,
having organized Greatest Asset Pty Ltd, a health and lifestyle improvement
company engaged in online learning, behavioral and lifestyle change and
improvement, offering services to health plans, corporate clients, medical
and health professionals, insurance providers, as well as the broader
general public in the health, education, information and wellness market. Signatures
Date: May 27, 2015
| American Biogenetic Sciences, Inc. |
| By: Richard Rubin, CEO |
| /s/ Richard Rubin |